): +; 011203#45167899...recent advances in cv risk reduction in type 2 diabetes management q&a...

9
CME Credits 10 – 11 July 2020 Program Hilton Habtoor Grand Hotel Beirut, Lebanon www.lsedl.org ANNUAL CONGRESS 23 rd Cardio-metabolic, Thyroid and Pituitary Diseases of the Lebanese Society of Endocrinology, Diabetes and Lipids UNDER THE PATRONAGE OF His Excellency the Minister of Public Health Dr Hamad Hassan https://zoom.us/webinar/register/WN_SdTiaX4HRUuMxXUNGzlIgw Congress Sessions Live on ZOOM Platform Click on the below link to Register:

Upload: others

Post on 22-Jul-2020

0 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: ): +; 011203#45167899...Recent Advances in CV Risk Reduction in Type 2 Diabetes Management Q&A Dr Marie Noel KALLAS CHEMALY Updates on Outcomes in Type 2 Diabetes Patients with Heart

CME Credits

10 – 11 July 2020

Program

Hilton Habtoor Grand HotelBeirut, Lebanonwww.lsedl.org

ANNUAL CONGRESS23rd

Cardio-metabolic, Thyroid andPituitary Diseases

of the Lebanese Society of Endocrinology, Diabetesand Lipids

UNDER THE PATRONAGE OFHis Excellency the Minister ofPublic Health Dr Hamad Hassan

https://zoom.us/webinar/register/WN_SdTiaX4HRUuMxXUNGzlIgw

Congress Sessions Live on ZOOM PlatformClick on the below link to Register:

Page 2: ): +; 011203#45167899...Recent Advances in CV Risk Reduction in Type 2 Diabetes Management Q&A Dr Marie Noel KALLAS CHEMALY Updates on Outcomes in Type 2 Diabetes Patients with Heart

Dear Colleagues and Friends, On behalf of the organizing committee, it is my pleasure to invite you all to the 23rd annual congress of the Lebanese Society of Endocrinol-ogy, Diabetes and lipids (LSEDL) that will be held on the 10th – 11th July 2020 at Hilton Habtoor Grand Hotel – Sin El Fil. The 23rd annual congress of the LSEDL is one of the premier congress-es, gathering top-notch leaders from different endocrinology fields becoming an excellent opportunity for best-practice exchange be-tween colleagues. This year’s congress theme will be: “Cardiometabol-ic, Thyroid and Pituitary Diseases”. Bringing together the leading specialists and researchers from the Middle East and prominent experts from Europe, the 23rd annual LSEDL congress will foster practice updates and science convergence. As al-ways, our mission is to fulfill the scientific expectations of the Lebanese and international colleagues. I would like to express my sincere recog-nition to the eminent speakers who accepted our invitation to be part in this event and discuss key enriching topics to our expertise.

The 23rd Annual Congress of the LSEDL promises a futuristic health care vision based on a medical legacy of excellence in health care and education.

It is our greatest honor and deepest privilege to welcome you; thank-ing you for your contribution to the success of this distinguished scien-tific event.

Looking forward to an interactive meeting. PAOLA ATALLAHPresident of the Lebanese Society of Endocrinology, Diabetes and Lipids

WELCOME LETTER

Page 3: ): +; 011203#45167899...Recent Advances in CV Risk Reduction in Type 2 Diabetes Management Q&A Dr Marie Noel KALLAS CHEMALY Updates on Outcomes in Type 2 Diabetes Patients with Heart

PRESIDENT OF THE CONGRESSDr Paola ATALLAH

EXECUTIVE COMMITTEEPresident Dr Paola ATALLAHVice President Dr Akram ECHTAYSecretary Dr Maya BARAKETreasurer Dr Hajjar BALLOUTMembers Dr Abbas NASSER Dr Carole SAADE RIACHY Dr Haitham ABOU DAHER Dr Rita MEDLEJ Dr Yasmine AKLE ORGANIZING COMMITTEEChair Dr Haitham ABOU DAHERMembers Dr Abbas NASSER Dr Yasmine AKLE

SCIENTIFIC COMMITTEEChair Dr Rita MEDLEJMembers Dr Akram ECHTAY Dr Carole SAADE RIACHY Dr Hajjar BALLOUT Dr Maya BARAKE Dr Paola ATALLAH Dr Selim JAMBART

COMMITTEE & SPEAKERS

INTERNATIONAL SPEAKERSDr Andreas LIEBL - GermanyDr Carel LE ROUX - Ireland Dr Chantal MATHIEU - BelgiumDr Fadi NABHAN - USADr Frederick Johan RAAL - South Africa Dr Glen MATFIN - United KingdomDr Juan Pablo FRIAS - USA Dr Leszek CZUPRYNIAK - PolandDr Robert BUSH - USADr Stephan JACOB - GermanyDr Tina VILSBOLL - DenmarkDr Vera POPOVIC-BRKIC - Serbia

LOCAL SPEAKERSDr Dana EL MASRI Dr Hala AHMADIEHDr Hala KERBAGE Dr Mireille EL AMMDr Ramzi ALAMEDDINE Dr Rita NEMRDr Roy RAADDr Sami AZAR Dr Selim NASSER

Page 4: ): +; 011203#45167899...Recent Advances in CV Risk Reduction in Type 2 Diabetes Management Q&A Dr Marie Noel KALLAS CHEMALY Updates on Outcomes in Type 2 Diabetes Patients with Heart

12h00-13h00

13h00-13h30

Moderators

13h30-13h55

13h55-14h00

Moderators

14h00-14h25

14h25-14h30

Moderators14h30-14h55

14h55-15h00

Moderators15h00-15h25

15h25-15h30

15h30-16h00

FRIDAY 10 JULY 2020Registration + Welcome Lunch

Opening Ceremony

Dr Frida ATALLAH Dr Rafi POLADIAN Male Hypogonadism Guidelines Q&A

Dr Jocelyne EID FARESDr Kamal HIRBLIFellow Challenging Case Presentation:SGLT2 Inhibitor Induced Hypercalcemia Q&A

Dr Elizabeth ABOU JAOUDERecent Advances in CV Risk Reduction in Type 2 Diabetes ManagementQ&A

Dr Marie Noel KALLAS CHEMALY Updates on Outcomes in Type 2 Diabetes Patients with Heart FailureQ&A

Coffee Break

Dr Hala AHMADIEH

Dr Dana EL MASRI

Dr Leszek CZUPRYNIAK

Dr Mireille EL AMM

Dr Paola ATALLAH - LSEDL PresidentDr Charaf ABOU CHARAF - President of the Lebanese Order of PhysiciansDr Hamad HASSAN - Minister of Public Health

Page 5: ): +; 011203#45167899...Recent Advances in CV Risk Reduction in Type 2 Diabetes Management Q&A Dr Marie Noel KALLAS CHEMALY Updates on Outcomes in Type 2 Diabetes Patients with Heart

Moderators16h00-16h25

16h25-16h30

Moderators16h30-16h55

16h55-17h00

Moderators

17h00-17h25

17h25- 17h30

Moderators

17h30-17h55

17h55-18h00

Moderators

18h00-18h2518h25-18h30

Dr Selim JAMBARTDyslipidemia & Residual Cardiovascular RiskQ&A

Dr Carole SAADEH RIACHYGetting to Goal: Evidence for Fixed Ratio Combinations in the Management of Type 2 Diabetes Q&A

Dr Mohammad EL RAWAS Dr Hussam GHOSNRadioactive Iodine from Diagnosis to TreatmentQ&A

Dr Grace JRADDr Marwan KRAYEMStress & Burnout Among Physicians in Times of Crisis: Screening & ManagementQ&A

Dr Mona NASRALLAHDr Ghassan KADDOUHApproach to Thyroid NodulesQ&A

Dr Robert BUSCH

Dr Juan Pablo FRIAS

Dr Roy RAAD

Dr Hala KERBAGE

Dr Fadi NABHAN

Page 6: ): +; 011203#45167899...Recent Advances in CV Risk Reduction in Type 2 Diabetes Management Q&A Dr Marie Noel KALLAS CHEMALY Updates on Outcomes in Type 2 Diabetes Patients with Heart

08h30 – 09h00

Moderators

09h00-09h25

09h25-09h30

Moderators

09h35-10h00

10h00-10h05

Moderators10h10-10h35

10h35 -10h40

Moderators10h45-11h10

11h10-11h15

11h15-11h45

Moderators11h45-12h10

12h10-12h15

Registration

Dr Ghada BAKHOSDr Georges HAJJPathologic Assessment and Molecular Biomarkers in the Mangement of Thyroid CarcinomasQ&A

Dr Charles SAABDr Georges KARAM Growth Hormone Replacement in AdultsQ&A

Dr Dana SLEIMANType 2 Diabetes and Cardiorenal Risk: The Role for Early SGLT2iQ&A

Dr Hajar BALLOUTWhat is Next After Metformin? Controlling Glycaemia & BeyondQ&A

Coffee Break

Dr Nancy NAKHOULVertis CV: Adding to the Un-derstanding of the SGLT2-IS Class with ErtugliflozinQ&A

Dr Selim NASSER

Dr Vera POPOVIC -BRKIC

Dr Stephan JACOB

Dr Tina VILSBOLL

Dr Sami AZAR

SATURDAY 11 JULY 2020

Page 7: ): +; 011203#45167899...Recent Advances in CV Risk Reduction in Type 2 Diabetes Management Q&A Dr Marie Noel KALLAS CHEMALY Updates on Outcomes in Type 2 Diabetes Patients with Heart

Moderators12h20-12h45

12h45-12h50

12h50-13h50

Moderators13h50-14h15

14h15-14h20

Moderators14h25-14h50

14h50-14h55

Moderators15h00- 15h25

15h25- 15h30

15h30-16h00

Moderators16h00-16h25

16h25-16h30

Dr Maya BARAKEObesity Management: Time to ActQ&A

Lunch Break

Dr Akram ECHTAYVERIFY & Early Treatment IntensificationQ&A

Dr Rita Maria CHIDIAC WEHBEIt is Time to Consider the Range: A New Perspective on Glycaemic ControlQ&A

Dr Mounzer SALEHDyslipidemia: A Step Towards Achieving Optimal Treatment Targets & Cardiovascular PreventionQ&A

Coffee Break

Dr Ali MOURADThe Established Role of DPP4i in the Management of Type 2 DiabetesQ&A

Dr Carel LE ROUX

Dr Chantal MATHIEU

Dr Andreas LIEBL

Dr Frederick Johan RAAL

Dr Rita NEMR

Page 8: ): +; 011203#45167899...Recent Advances in CV Risk Reduction in Type 2 Diabetes Management Q&A Dr Marie Noel KALLAS CHEMALY Updates on Outcomes in Type 2 Diabetes Patients with Heart

Moderators

16h35-17h00

17h00-17h05

Moderators

17h10-17h35

17h35-17h40

Moderators17h45-18h10

18h10-18h15

Dr Emile ANDARYDr Marie Helene GHANNAGEAutoimmune Disease of the PituitaryQ&A

Dr Rola ABOU KHALILDr Ghada BALLANThyroid Eye Disease- Connecting Endocrinology with OphthalmologyQ&A

Dr Rita MEDLEJCardiorenal Metabolic Approach: A Necessity in Type 2 Diabetes ManagementQ&A

Dr Vera POPOVIC -BRKIC

Dr Ramzi ALAMEDDINE

Dr Glen MATFIN

SATURDAY 11 JULY 2020

Page 9: ): +; 011203#45167899...Recent Advances in CV Risk Reduction in Type 2 Diabetes Management Q&A Dr Marie Noel KALLAS CHEMALY Updates on Outcomes in Type 2 Diabetes Patients with Heart